High sensitivity C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation

摘要：

Background C-reactive protein (CRP) is one of the acute phase proteins that increase during systemic inflammation.It”s been suggested that testing CRP levels in the blood may be an additional way to assess cardiovascular disease risk.A more sensitive CRP test, called a highly sensitive C-reactive protein (hs-CRP) assay, is available to determine heart disease risk.However, the association between CRP and stent thrombosis after drug-eluting stent implantation has not been defined.So we designed this study to investigate in a follow-up study whether high-sensitivity C-reactive protein(hs-CRP) predicts coronary heart disease (CHD) events and stent thrombosis in subjects undergone drug-eluting stent implantation.

作者: HU Bin ZHOU Yu-jie LIU Yu-yang SHI Dong-mei ZHAO Ying-xin

作者单位: Beijing Anzhen Hospital Affiliated to Capital Medical University Beiing Institute of Heart Lung and Blood Vessel Diseases

会议类型: 国内会议

会议名称: 第11届中国介入心脏病学大会

会议地点: 北京

会议语种:英文

页码: 72-72

在线出版日期: 2013-03-20（万方平台首次上网日期，不代表论文的发表时间）